B I O P E O P L E
Dhananjay Singh appointed as new Managing Director of Merck Life Science in India
Merck , a leading science and technology company , has recently appointed Dhananjay Singh as the Managing Director of Merck Life Science in India , in addition to his current position as Head of Science & Lab Solutions Commercial , India . Effective April 1 , 2024 , Dhananjay Singh has taken over from Sreenath NS , who is retiring after 36 years of illustrious service with Merck in India .
In his role as the Managing Director , Dhananjay Singh will be responsible for driving the Life Science strategy in India , ensuring governance and compliance alongside other leaders from Merck ’ s businesses in India . Dhananjay Singh joined Sigma-Aldrich in 1997 . Over the years he took on several leadership roles in Commercial Organisation before his appointment as Head of Science & Lab Solutions Commercial for India , a position he held since 2022 .
G S Krishnan re-elected ABLE President for 2024 -2026
G S Krishnan , President of ABLE ( Association of Biotechnology Led Enterprises ) has been re-elected for another two-year term from April 2024 – 2026 , as the head of India ’ s leading biotech industry organization . G S Krishnan , with three decades of experience in the Bio Industrial sector , currently – Director , external stakeholder relations at Danish biotech company , Novonesis and Independent Consultant / Advisor to various Biotech companies , assumed ABLE president ’ s role in April 2021 .
Dr Kiran Mazumdar-Shaw will continue as the association ’ s honorary non-executive chairperson . The other office bearers will be Vice President : Dr Deepanwita Chattopadhyay , Chairperson of IKP , Hyderabad ; General Secretary : Dr Ezhil Subbian , co-founder and CEO , String Bio , Bangalore and Treasurer : Ravi Bhola , senior Partner , K & S Partners , Bangalore .
72
BioVoiceNews | May / June 2024